the safety behind ingredients in nail products march 2, … · 2018-10-05 · committee (inc) and...
TRANSCRIPT
THE SAFETY BEHIND INGREDIENTS
IN NAIL PRODUCTS
March 2, 2017
PCPC - WHO WE ARE
• Founded in 1894
• The leading national trade association for the cosmetic and personal care products industry.
• Represent more than 600 member companies: • 325 manufacture or distribute personal care products • 300 supply goods and services
• Council Departments include Science, Legal, International,
Legislative, Public Affairs and Marketing.
• We are the voice on scientific, legal, regulatory, legislative and international issues for the personal care product industry.
Introduction
MYTH: Cosmetics are not regulated
FACT: Cosmetics are not “pre-approved”
but are absolutely regulated!
AGENDA
The Government
o U.S. Food Drug and Cosmetic Act
o FDA Authority
Third-Party
o CIR
Industry
o INCI, AERS, CosmeticsInfo.org
3 Pillars Assuring Safety and Quality
What Does the Law Say?
U.S. FD&C Act:
• Cosmetic products and ingredients must be safe for
consumers under labeled or customary conditions of use
• Companies and individuals who market cosmetics have a
legal responsibility for the safety of their products and
ingredients.
• Prohibits adulterated or misbranded cosmetics whether
from ingredients, contaminants, processing, packaging,
or shipping
THE GOVERNMENT
FDA Authority
• Conduct Inspections of manufacturing plants
• Issue Warning Letters
• Request Voluntary Recalls
• Domestic -- Working with Department of Justice
Have a restraining order issued
Seize Products
Up to and Including Criminal prosecution.
• Imports -- With Customs and Border Protection
Prevent Entry (Most instances where FDA has exercised
this authority have involved Drug claims or
unapproved color additives)
THE GOVERNMENT
Adverse Event Reporting
• CFSAN Adverse Event Reporting System(CAERS)
• Data on adverse events and product
complaints reported about food, dietary
supplements and cosmetics.
• Receives from multiple sources
• Consumers, Health Professionals, Industry
and Others
THE GOVERNMENT
Adverse Event Reports
• This includes 1208 reports on one product
• 70% non-serious
• 122 Billion Units sold in 2010* = 0.004 reports/million units
• Compare:
• Consumer AE Reports to FAERS on Drugs in 2014 = 823,813†
* Rexam Consumer packaging Report 2011/12, “Packaging Unwrapped”
† http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm070456.htm
THE GOVERNMENT
2004-2016 Q3: 4,320 unique reports on
cosmetics or about 340 per year
over the last 13 years
Adverse Events associated with personal care products are extremely rare
Present practices are proven to work!
THE GOVERNMENT
3rd PARTY CONFIRMATION
The purpose of CIR is to determine those
cosmetic ingredients for which there is a
reasonable certainty in the judgment of
competent scientists that the ingredient is
safe under its conditions of use.
Cosmetic Ingredient Review
• CIR established in 1976 with support of FDA and Consumer Federation of America.
• The CIR and review process are independent from Council and the cosmetics industry.
• The safety of ingredients used in cosmetics are thoroughly reviewed and assessed in an open, unbiased, and expert manner.
• The results are publishes in the open, peer-reviewed scientific literature.
3rd PARTY CONFIRMATION
CIR Expert panel
Dermatologists: • Chair, Wilma F. Bergfeld, MD, FACP – Cleveland Clinic • Team Leader, Donald V. Belsito, MD – Columbia University • Team Leader, James G. Marks, MD – Penn State College of Medicine
Toxicologists/Pathologists:
• Curtis D. Klaassen, PhD – University of Kansas Medical Center • Ronald C. Shank, PhD – University of California, Irvine • Thomas J. Slaga, PhD – University of Texas Health Science Center • Paul W. Snyder, DVM, PhD – Purdue University
Chemists:
• Daniel C. Liebler, PhD – Vanderbilt University • Ronald A. Hill, PhD – University of Louisiana at Monroe
Non-Voting Liaisons:
• Beth Jonas, PhD – representing industry • Linda Katz, MD – representing government • Rachel Weintraub, JD – representing consumers
CIR Assessment Process
• Set Priorities
• “Frequency of Use” as surrogate for exposure
• Specific safety concerns
• Develop Assessments
• Gather all published studies/reviews
• Solicit comment and unpublished data; Summarize the findings
• Panel review; identify data needs
• Incorporate all new data in report
• Panel review of all data, incl. new information
• Public deliberation / Make decision
• Publish results in peer reviewed journal
CIR Reports on Safety of Ingredients
All final CIR reports
are published in the
International Journal
of Toxicology
3rd PARTY CONFIRMATION
CIR: AN OBJECTIVE RESOURCE
• Safety data on over 4,800 cosmetic ingredients
• Reviews for each ingredient often include hundreds of studies
3rd PARTY CONFIRMATION
INCI
What is INCI?
International Nomenclature Cosmetic Ingredient (INCI)
• INCI names are developed by the International Nomenclature
Committee (INC) and published in the International Cosmetic
Ingredient Dictionary and Handbook.
• INCI names are uniform, systematic names internationally
recognized to identify cosmetic ingredients. In the U.S. and
many countries around the world, INCI names are referenced in
regulations that establish ingredient labeling for cosmetic
products.
INDUSTRY INITIATIVES
What is the INCI Dictionary?
• What: Technical compendium containing the INCI names and related
information for cosmetic ingredients.
• Use: Provides world community with accurate, transparent, and
harmonized nomenclature.
• How: By working with national governments, trade associations, and
other organizations to ensure that rules for harmonization of INCI
labeling names are developed to accommodate differing approaches in
national laws and regulations.
• Why: To have a single worldwide reference, based on sound scientific
principles, that allows the identification of the composition of personal
care products.
• Why: Harmonization is essential to the global free movement of goods.
INDUSTRY INITIATIVES
INCI
What INCI is not:
INCI is not an endorsement of an ingredient’s safety or
acceptability for use in a cosmetic.
INCI is not a pre-approved list of ingredients for any country.
It is the responsibility of the finished product manufacturer to
substantiate safety and to comply with current regulatory
requirements for the intended market
INDUSTRY INITIATIVES
INCI – Key Points
• Uniform ingredient labeling names promote a common
understanding of cosmetic composition throughout the
world
• The safety and regulatory status of ingredients can be
efficiently tracked on a global basis
• INCI system is based on sound-science which contributes to
its success
• Consumer health benefit of being able to recognize an
ingredient they may want to avoid (e.g., due to allergies)
regardless of where it’s made or sold
INDUSTRY INITIATIVES
• Cosmeticsinfo.org is an information Web site that includes
factual, scientific information on ingredients most
commonly used in cosmetics and personal care products in
the United States.
• The site is divided into two primary sections; (1) safety
information pages and (2) an ingredient database.
• Sets out how cosmetics are regulated in the U.S. and abroad,
components of cosmetic ingredient labeling, the authority of
the U.S. Food and Drug Administration (FDA) to regulate
cosmetics, and how companies evaluate the safety and
efficacy of their products.
COSMETICSINFO.ORG
INDUSTRY INITIATIVES
Includes CIR summaries and other scientific perspective
from regulatory agencies and 3rd parties
COSMETICSINFO.ORG
INDUSTRY INITIATIVES
Conclusions
• Cosmetics are regulated – cosmetics are safe
• Industry responsibility coupled with FDA oversight and CIR
third-party review has proven effective with any type of
adverse event being extremely rare.
• Consumer safety is the number one priority for cosmetic
and personal care products companies
Thank You
Thomas F. Myers, Esq. EVP - Legal & General Counsel Personal Care Products Council 1620 L Street, NW Washington, D.C. 20036 202-331-1770 [email protected]